GO:0010557 positive regulation of macromolecule biosynthetic process: Biosynthetic Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010557 describes any process that increases the rate, frequency or extent of macromolecule biosynthesis, covering DNA, RNA, protein and polysaccharide production.
• It is a biological_process term that sits high in the GO hierarchy and integrates transcriptional, post-transcriptional and translational control.
• mTOR signaling is a central positive regulator of macromolecule biosynthesis, controlling ribosome biogenesis and protein synthesis.
• Dysregulation of this process is linked to cancer, neurodegeneration, metabolic disease and developmental disorders [3,5,6].
• Key experimental approaches include transcriptomics, proteomics, ribosome profiling and CRISPR-based perturbation [4,8].
• EDITGENE provides knockout, point-mutation, knock-in, overexpression and library screening services to dissect this process.
Description
Positive regulation of macromolecule biosynthetic process (GO:0010557) is a broad biological_process term that captures any mechanism increasing the production of large polymeric molecules such as nucleic acids, proteins and polysaccharides. It is not a single pathway but a regulatory hub that integrates signals from growth factors, nutrients and stress to adjust the cell's biosynthetic output. Because macromolecule biosynthesis consumes most of a cell's energy and building blocks, its positive regulation is tightly coupled to cell growth, proliferation and survival. Researchers study GO:0010557 to understand how cells ramp up production of DNA, RNA and protein during development, immune activation and tissue regeneration [5,8]. The term is also central to disease biology, as unchecked biosynthetic activity supports tumor growth while insufficient activity contributes to neurodegeneration and sarcopenia [3,4,6]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to explain the definition, mechanisms, key genes, disease links and experimental models for GO:0010557.
positive regulation of macromolecule biosynthetic process At A Glance
| GO ID | GO:0010557 |
|---|---|
| GO term | positive regulation of macromolecule biosynthetic process |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Increases the rate, frequency or extent of macromolecule biosynthesis, including nucleic acids, proteins and polysaccharides |
| Parent terms | positive regulation of macromolecule metabolic process; regulation of macromolecule biosynthetic process |
| Child terms | positive regulation of gene expression; positive regulation of translation; positive regulation of DNA replication; positive regulation of RNA biosynthetic process |
| Related processes | mTOR signaling, ribosome biogenesis, unfolded protein response, growth factor signaling |
| Taxonomic scope | All cellular organisms |
What Is GO:0010557?
In plain terms, GO:0010557 describes any cellular process that speeds up or increases the amount of macromolecules a cell makes. The official QuickGO definition states: Any process that increases the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass. This means the term covers positive regulation of DNA replication, transcription, RNA processing, translation and polysaccharide synthesis, but only the regulatory component that increases these processes, not the biosynthetic reactions themselves.
Why Is positive regulation of macromolecule biosynthetic process Important in Cell Biology?
GO:0010557 matters because it defines the regulatory logic that cells use to match macromolecule production with demand. When this positive regulation fails, cells cannot build enough protein or nucleic acid to maintain proteostasis, leading to neurodegeneration, sarcopenia and developmental defects [4,5]. When it is overactive, cells accumulate biomass and divide uncontrollably, a hallmark of cancer [3,6]. Understanding this term therefore helps researchers interpret transcriptomic and proteomic data, design perturbation experiments and identify therapeutic targets that tune biosynthetic output rather than blocking it entirely [7,8].
• Controls cell growth and proliferation by matching macromolecule synthesis to nutrient availability.
• Integrates growth factor, amino acid and energy signals through mTOR and related kinases.
• Dysregulated in cancer, where increased protein and nucleic acid synthesis supports tumor growth [3,6].
• Impaired in neurodegeneration and sarcopenia, contributing to loss of proteostasis and muscle wasting [4,5].
• Essential for immune cell activation and antibody production.
• Required for embryonic development and organogenesis.
• Modulated by autophagy and lysosomal degradation pathways that recycle building blocks.
• Target of therapeutic strategies in metabolic disease and aging.
• Serves as a functional annotation hub for interpreting omics data.
• Enables CRISPR screens to identify positive regulators of biosynthesis.
What Happens During positive regulation of macromolecule biosynthetic process?
Signal perception and mTOR activation
In simple terms: The cell senses nutrients and growth factors, then flips a master switch called mTOR to start making macromolecules.
Positive regulation of macromolecule biosynthesis begins with signal perception. Growth factors, amino acids and energy status converge on the mechanistic target of rapamycin (mTOR), which integrates these cues to promote anabolic processes. mTOR controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins, demonstrating its role in developmental biosynthesis. When active, mTOR phosphorylates downstream effectors that drive ribosome biogenesis, translation initiation and lipid synthesis, thereby increasing the overall rate of macromolecule production.
Transcriptional amplification of biosynthetic genes
In simple terms: The cell makes more mRNA copies of the genes needed to build macromolecules.
A key step in positive regulation is increased transcription of genes encoding ribosomal proteins, translation factors and metabolic enzymes. In porcine oocytes during in vitro maturation, new markers for regulation of transcription and macromolecule metabolic process were identified, showing that transcriptional programs are remodeled to support biosynthetic demand. This transcriptional amplification ensures that the machinery for protein synthesis is abundant when cells prepare for growth or division.
Ribosome biogenesis and translational control
In simple terms: The cell builds more ribosomes and uses them to translate mRNA into protein faster.
Positive regulation of macromolecule biosynthesis heavily depends on ribosome biogenesis and translation. mTOR promotes the synthesis of ribosomal RNA and ribosomal proteins, and it enhances cap-dependent translation initiation. In C. elegans, metabolic analysis of sarcopenic muscle identified positive modulators of longevity and healthspan, linking translational capacity to organismal aging. These mechanisms collectively increase the rate at which new proteins are synthesized [4,7].
Post-transcriptional and post-translational feedback
In simple terms: The cell uses feedback loops to keep macromolecule production balanced.
Positive regulation is not linear; it is buffered by feedback. Autophagy, regulated by AMBRA1, can either supply or degrade macromolecules, thereby modulating biosynthetic flux during vertebrate development. Allostery and conformational changes in enzymes can also adjust pathway output in response to metabolite levels. Such feedback ensures that macromolecule biosynthesis matches cellular needs and prevents wasteful overproduction [2,5].
Integration with cell cycle and differentiation
In simple terms: Macromolecule production is timed with cell division and specialization.
Cells coordinate macromolecule biosynthesis with the cell cycle and differentiation programs. mTOR controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins, showing that positive regulation of biosynthesis is coupled to cell fate decisions. In atherosclerosis, matricellular proteins modulate biosynthetic and inflammatory processes in the vessel wall. This integration ensures that cells build sufficient biomass before dividing or adopting specialized functions [3,7].
Key Genes Involved in GO:0010557 positive regulation of macromolecule biosynthetic process
The following genes and proteins are experimentally implicated in positive regulation of macromolecule biosynthetic process, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Central kinase integrating nutrient and growth factor signals to promote biosynthesis | Target for rapamycin and analogs; studied in cancer and aging |
| AMBRA1 | Regulates autophagy and development, influencing macromolecule turnover | Knockout models show developmental defects |
| S100A proteins | Modulate inflammation and biosynthetic activity in glioblastoma microenvironment | Markers of tumor-associated inflammation |
| Matricellular proteins | Regulate extracellular matrix and biosynthetic processes in atherosclerosis | Potential therapeutic targets in vascular disease |
| N-methylserotonin pathway genes | Microbial metabolism linked to host biosynthetic regulation | Studied in gnotobiotic mice and human gut microbiome |
| Ribosomal protein genes | Build ribosomes for protein synthesis | Frequently mutated in ribosomopathies |
| Translation initiation factors | Control cap-dependent translation | Targets for cancer therapy |
| Transcription factors (e.g., MYC) | Amplify transcription of biosynthetic genes | Oncogenic drivers |
| Autophagy-related genes | Supply building blocks for biosynthesis | Modulate biosynthetic flux |
| Centrosomal proteins | Support cell cycle and biosynthetic capacity | Linked to differentiation |
| Allosteric enzymes | Adjust pathway flux via conformational changes | Targets for allosteric drugs |
| Longevity modulators | Positive modulators of healthspan in C. elegans | Aging research |
| Inflammatory mediators | Link inflammation to biosynthetic activation | Glioblastoma microenvironment |
| Metabolic enzymes | Provide precursors for macromolecule synthesis | Sarcopenia and metabolic disease |
| Signaling adaptors | Transmit growth signals to biosynthetic machinery | Cancer and development |
| Proteostasis regulators | Maintain protein quality during increased synthesis | Neurodegeneration |
How Is positive regulation of macromolecule biosynthetic process Regulated?
Positive regulation of macromolecule biosynthetic process is controlled by a layered network. mTOR is the best-characterized positive regulator, responding to growth factors and amino acids to activate translation and ribosome biogenesis. Autophagy, regulated by AMBRA1, can either supply or degrade macromolecules, thereby modulating biosynthetic flux. Allosteric regulation of metabolic enzymes provides rapid, reversible control of pathway output. In addition, transcriptional programs remodeled during oocyte maturation illustrate how cells adjust biosynthetic capacity in response to developmental cues. These regulatory layers ensure that macromolecule production is matched to cellular demand and environmental conditions [2,5,7,8].
positive regulation of macromolecule biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Cancer, metabolic disease, aging | Kinase-dead knock-in; conditional knockout |
| AMBRA1 | Neurodegeneration, developmental defects | Knockout zebrafish or mouse |
| S100A proteins | Glioblastoma | Overexpression in glioma cell lines |
| Matricellular proteins | Atherosclerosis | ApoE knockout mouse with knock-in |
| Ribosomal protein genes | Ribosomopathies | Point-mutation knock-in in hematopoietic cells |
Cancer
Many cancers hijack positive regulation of macromolecule biosynthesis to sustain rapid growth. Matricellular proteins in atherosclerosis development also influence biosynthetic and inflammatory processes in the tumor microenvironment. S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture, linking biosynthetic activation to tumor progression. Targeting mTOR and downstream translation factors is a major therapeutic strategy.
Neurodegeneration and aging
Impaired positive regulation of macromolecule biosynthesis contributes to loss of proteostasis in aging and neurodegeneration. Metabolic analysis of sarcopenic muscle identified positive modulators of longevity and healthspan in C. elegans, highlighting the link between biosynthetic capacity and muscle aging. AMBRA1-regulated autophagy in vertebrate development also affects neuronal survival, and its dysregulation is implicated in neurodegeneration.
Metabolic and developmental disorders
Disrupted biosynthetic regulation underlies developmental defects and metabolic disease. mTOR controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins, and its perturbation leads to differentiation defects. In porcine oocytes, markers for regulation of transcription and macromolecule metabolic process change during in vitro maturation, reflecting the importance of biosynthetic control in reproduction.
From positive regulation of macromolecule biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is MTOR required for biosynthetic activation? | CRISPR knockout of MTOR in HEK293T or cancer cell lines |
| Does a point mutation in a ribosomal protein impair translation? | Point-mutation knock-in via CRISPR in iPSCs |
| Can overexpression of a transcription factor drive macromolecule synthesis? | Doxycycline-inducible overexpression in fibroblasts |
| What is the role of AMBRA1 in autophagy and biosynthesis? | AMBRA1 knockout mouse or zebrafish |
| How does S100A protein distribution affect glioblastoma? | Tagged knock-in of S100A in glioma cells |
| Which genes positively regulate biosynthesis? | Genome-wide CRISPR activation library screening |
How to Study the positive regulation of macromolecule biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | mRNA levels of biosynthetic genes | Transcriptional profiling after CRISPR perturbation |
| Ribo-seq | Translation efficiency and ribosome occupancy | Global protein synthesis measurement |
| Proteomics | Protein abundance and modifications | Validating biosynthetic output |
| Immunofluorescence | Spatial distribution of proteins | Tumor microenvironment studies |
| CRISPR knockout screen | Gene requirement for biosynthesis | Identifying positive regulators |
| CRISPR activation screen | Gene sufficiency to drive biosynthesis | Gain-of-function screening |
| Metabolic flux analysis | Precursor incorporation into macromolecules | Measuring biosynthetic rate |
| Bioinformatics enrichment | GO term enrichment of hits | Mapping to GO:0010557 |
Transcriptomics and RNA-seq
RNA sequencing measures changes in mRNA levels of biosynthetic genes, providing a global view of transcriptional amplification. In porcine oocytes, RNA-seq identified new markers for regulation of transcription and macromolecule metabolic process during in vitro maturation. This method is ideal for comparing wild-type and CRISPR-perturbed cells to identify positive regulators.
Proteomics and ribosome profiling
Mass spectrometry-based proteomics quantifies protein abundance, while ribosome profiling (Ribo-seq) measures translation efficiency. These methods directly assess the output of positive regulation of macromolecule biosynthesis. In C. elegans, metabolic analysis combined with proteomics identified positive modulators of longevity and healthspan. Ribo-seq can reveal whether mTOR activation increases global translation.
Imaging and reporter assays
Fluorescent reporters for ribosomal RNA or nascent protein synthesis enable live-cell imaging of biosynthetic activity. S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture, which can be visualized by immunofluorescence. These assays are useful for validating CRISPR knock-in of tagged biosynthetic proteins.
CRISPR screens and functional genomics
Pooled CRISPR knockout or activation screens identify genes that positively regulate macromolecule biosynthesis. Such screens have been used to find modulators of healthspan in C. elegans and to dissect mTOR-dependent pathways [4,7]. Bioinformatics analysis of screen hits maps them to GO:0010557 and related terms.
How CRISPR Can Be Used to Study GO:0010557 positive regulation of macromolecule biosynthetic process
Knockout
CRISPR knockout of candidate positive regulators such as MTOR or AMBRA1 tests whether they are required for macromolecule biosynthesis. For example, AMBRA1 knockout in zebrafish reveals developmental defects linked to autophagy and biosynthetic control. Knockout models are essential for loss-of-function studies of GO:0010557.
Point Mutation
Point-mutation knock-in via CRISPR can mimic disease-associated variants in biosynthetic genes, such as ribosomal protein mutations found in ribosomopathies. These models allow precise dissection of how single amino acid changes alter macromolecule production without confounding effects of complete gene loss.
Knock-in
Tagged knock-in of endogenous genes, such as S100A proteins, enables visualization and purification of biosynthetic complexes in their native context. Knock-in of reporter cassettes under biosynthetic promoters provides real-time readouts of GO:0010557 activity.
Overexpression
CRISPR activation or cDNA overexpression of transcription factors like MYC drives macromolecule biosynthesis and can transform cells. Overexpression models are useful for identifying sufficiency of a gene to activate GO:0010557 and for testing therapeutic inhibitors.
How EDITGENE Supports positive regulation of macromolecule biosynthetic process Research
Researchers studying positive regulation of macromolecule biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in driving or restraining biosynthesis. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of macromolecule biosynthetic process research.
Frequently Asked Questions About positive regulation of macromolecule biosynthetic process
What is GO:0010557?
GO:0010557 is the Gene Ontology term for positive regulation of macromolecule biosynthetic process, describing any process that increases the rate, frequency or extent of macromolecule biosynthesis.
What genes are involved in positive regulation of macromolecule biosynthetic process?
Key genes include MTOR, AMBRA1, ribosomal protein genes, translation initiation factors and transcription factors such as MYC [5,7,8].
How is macromolecule biosynthesis positively regulated?
It is positively regulated by signaling pathways such as mTOR, which respond to nutrients and growth factors to enhance transcription, ribosome biogenesis and translation.
What diseases are linked to GO:0010557?
Dysregulation is linked to cancer, neurodegeneration, sarcopenia, atherosclerosis and developmental disorders [3,4,5,6].
What is the difference between macromolecule biosynthesis and its positive regulation?
Macromolecule biosynthesis refers to the actual synthesis reactions, while positive regulation refers to processes that increase the rate or extent of those reactions.
Which experimental methods study positive regulation of macromolecule biosynthesis?
RNA-seq, Ribo-seq, proteomics, immunofluorescence and CRISPR screens are commonly used [4,6,8].
How does mTOR regulate macromolecule biosynthesis?
mTOR phosphorylates downstream effectors that drive ribosome biogenesis and translation initiation, increasing protein synthesis.
Can CRISPR be used to study GO:0010557?
Yes, CRISPR knockout, knock-in, point mutation and activation screens are powerful tools to dissect this process [4,5,7].
What is the role of autophagy in macromolecule biosynthesis?
Autophagy can supply or degrade macromolecules, thereby modulating biosynthetic flux, as shown for AMBRA1.
Why is GO:0010557 important for cancer research?
Cancer cells often hijack positive regulation of macromolecule biosynthesis to sustain rapid growth, making it a therapeutic target [3,6].
Conclusion
GO:0010557 positive regulation of macromolecule biosynthetic process is a central biological_process term that integrates signaling, transcription and translation to control cellular biomass. Its dysregulation underlies major diseases including cancer, neurodegeneration and metabolic disorders [3,4,5,6]. By combining QuickGO annotation with CRISPR-based models and multi-omics methods, researchers can dissect the causal genes and pathways that drive or restrain this process [7,8]. EDITGENE offers comprehensive services to support these studies.
References
- 1. Han ND et al.. 2022. Microbial liberation of N-methylserotonin from orange fiber in gnotobiotic mice and humans.. Cell 185(14):2495-2509.e11 PMID: 35764090
- 2. Morea V et al.. 2024. Is allostery a fuzzy concept?. FEBS Open Bio 14(7):1040-1056 PMID: 38783588
- 3. Pervaiz N et al.. 2023. Matricellular proteins in atherosclerosis development.. Matrix Biol 120:1-23 PMID: 37086928
- 4. Jonk SM et al.. 2025. Metabolic analysis of sarcopenic muscle identifies positive modulators of longevity and healthspan in C. elegans.. Redox Biol 85:103732 PMID: 40544604
- 5. Antonioli M et al.. 2015. AMBRA1-regulated autophagy in vertebrate development.. Int J Dev Biol 59(1-3):109-17 PMID: 26374532
- 6. Cómitre-Mariano B et al.. 2025. S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture.. Theranostics 15(2):726-744 PMID: 39744679
- 7. Bankolé A et al.. 2025. mTOR controls ependymal cell differentiation by targeting the alternative cell cycle and centrosomal proteins.. EMBO Rep 26(12):3075-3105 PMID: 40307619
- 8. Brązert M et al.. 2020. New markers for regulation of transcription and macromolecule metabolic process in porcine oocytes during in vitro maturation.. Mol Med Rep 21(3):1537-1551 PMID: 32016446
